Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by National Cancer Center, Korea
Sponsor:
Information provided by (Responsible Party):
Sang-Jae Park, National Cancer Center, Korea
ClinicalTrials.gov Identifier:
NCT01333124
First received: April 1, 2011
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)